Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions
MedComm · 2026-02 · 7 (2)
DOI: 10.1002/mco2.70603 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 31.01.2026. Verfasst von Xuxia Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Research Center China Academy of Chinese Medical Sciences Beijing China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Biomedical research models are undergoing continuous evolution, while conventional models (two‐dimensional/ three‐dimensional cultures and animal studies) face limitations in physiological relevance and ethical constraints. Against this backdrop, the integration of organ‐on‐a‐chip (OoC) technology with multi‐omics methodologies is driving a profound paradigm shift in the field. OoC platforms utilize microfluidic technology to construct biomimetic three‐dimensional microenvironments capable of highly simulating human physiological and pathological states, while multi‐omics technologies (e.g., proteomics, transcriptomics, and metabolomics) provide systematic molecular profiling capabilities. The integration of these two approaches enables multi‐scale mechanistic analysis from molecular networks to the tissue level, significantly enhancing their potential in drug development and personalized medicine strategies. This article systematically reviews the research progress and existing challenges in this interdisciplinary field, with a focus on: (1) The developmental trajectory of OoC platforms from two‐dimensional to biomimetic three‐dimensional systems; (2) mechanistic insights revealed by the integration of multi‐omics and OoC technology in modeling disease processes; and (3) key issues in the standardization and clinical translation of OoC technology. Finally, the paper proposes a development roadmap for constructing next‐generation disease models, aiming to provide a theoretical framework and strategic guidance for the establishment of standardized systems and clinical translation pathways in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Research Center China Academy of Chinese Medical Sciences Beijing China.
- BinZhou Medical University Yantai City China.
- Guang 'anmen Hospital China Academy of Chinese Medical Sciences Beijing China.
- Institute of Traditional Chinese Medicine Health Industry China Academy of Chinese Medical Sciences Nanchang China.
- Analysis of Complex Effects of Proprietary Chinese Medicine Hunan Provincial Key Laboratory Yongzhou China.
ORCID-Profile: Peng Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cao, X., Xia, C., Li, C., Deng, S., Cao, J., Yang, H., Wang, S., & Chen, P. (2026). Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions. MedComm, 7(2). https://doi.org/10.1002/mco2.70603
Vancouver
Cao X, Xia C, Li C, Deng S, Cao J, Yang H, et al. Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions. MedComm. 2026;7(2). doi:10.1002/mco2.70603
BibTeX
@article{Cao2026,
author = {Cao, Xuxia and Xia, Congmin and Li, Caifeng and Deng, Shiwen and Cao, Junxian and Yang, Hongjun and Wang, Shaoping and Chen, Peng},
title = {Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions},
journal = {MedComm},
year = {2026},
volume = {7},
number = {2},
doi = {10.1002/mco2.70603}
}
EUVIMED